These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7363015)
1. Drug lag bad: drug lack worse. Br Med J; 1980 Mar; 280(6215):670. PubMed ID: 7363015 [No Abstract] [Full Text] [Related]
2. How bad the drug lag? Clark M; Hager M; Gosnell M Newsweek; 1978 Oct; 92(15):119, 121. PubMed ID: 10297213 [No Abstract] [Full Text] [Related]
3. Drug industry trying to change FDA's slow but sure policy. Demkovich LE Natl J (Wash); 1979 Jul; 11(29):1211-5. PubMed ID: 10242491 [No Abstract] [Full Text] [Related]
4. Knowledge is power: legislative control of drug industry trade secrets. O'Reilly JT Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981 [No Abstract] [Full Text] [Related]
5. Medical costs and the drug industry. Schwartz H Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744 [No Abstract] [Full Text] [Related]
6. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984. Lewis RA J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987 [No Abstract] [Full Text] [Related]
7. The FDA's restrictions against prescription drug advertising: more hindrance than help. Lorman AJ Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942 [No Abstract] [Full Text] [Related]
8. Recent developments help the defense of drug companies in 10b-5 cases. Salpeter AN; Hutchins H Food Drug Law J; 1996; 51(3):345-53. PubMed ID: 11797711 [No Abstract] [Full Text] [Related]
9. Drug product liability and health care delivery systems. Sage WM Stanford Law Rev; 1988 Apr; 40(4):989-1026. PubMed ID: 10318110 [No Abstract] [Full Text] [Related]
10. AIDS and the politics of drug lag. Vogel D Public Interest; 1989; (96):73-85. PubMed ID: 10294053 [No Abstract] [Full Text] [Related]
11. Drug lag '80: the missing medicines. Rhein RW Med World News; 1980 Sep; 21(18):31-48. PubMed ID: 10317008 [No Abstract] [Full Text] [Related]
12. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices. Moken MC Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247 [No Abstract] [Full Text] [Related]
13. The International Conference on Harmonization common technical document--global submission format? Molzon JA Food Drug Law J; 2005; 60(3):447-51. PubMed ID: 16304749 [No Abstract] [Full Text] [Related]
14. Personal responsibility and the Food and Drug Law. Janssen WF FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122 [No Abstract] [Full Text] [Related]
15. Extra-label drug use--pharmaceutical industry view. Welser JR J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571 [No Abstract] [Full Text] [Related]
16. The impact of regulation on pharmaceutical research expenditures: a dynamic approach. Wiggins SN Econ Inq; 1983 Jan; 21(1):115-28. PubMed ID: 10259900 [TBL] [Abstract][Full Text] [Related]
17. When does compounding become manufacturing? Gushee J J Am Vet Med Assoc; 1994 Jul; 205(2):235-6. PubMed ID: 7928585 [No Abstract] [Full Text] [Related]
18. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective. Terry M Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759 [No Abstract] [Full Text] [Related]
19. Stricter drug legislation. J Indiana State Med Assoc; 1968 Jun; 61(6):739. PubMed ID: 5668667 [No Abstract] [Full Text] [Related]
20. Drug research and social profit. Markoe F Med Mark Media; 1978 Sep; 13(9):10, 12, 14 passim. PubMed ID: 10238519 [No Abstract] [Full Text] [Related] [Next] [New Search]